Paper
6 December 2022 Design and synthesis of a novel albumin-bound PTX liposome system
Haoxin Li, Fang Chen
Author Affiliations +
Proceedings Volume 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022); 124583L (2022) https://doi.org/10.1117/12.2660283
Event: International Conference on Biomedical and Intelligent Systems, 2022, Chengdu, China
Abstract
Paclitaxel (PTX), a definited drug with anti-tumor effect, has been employed in treating various kinds of cancer. However, clinical effects have been hampered by its poor solubility and serious side effects. In this work, we developed an albumin-polymer liposome system for delivering PTX. Maleimide (MI) was employed to facilitate PTX binding with albumin, and liposome was comprised with lecithin and cholesterol. The albumin-bound PTX liposome system exhibited a high encapsulation efficiency, excellent drug load and good particle size. Combination of albumin and liposome, this system has the property to target in tumor issues and PTX could be released in tumor microenvironment by breaking the hydrazone bond to exhibit antitumor activity.
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Haoxin Li and Fang Chen "Design and synthesis of a novel albumin-bound PTX liposome system", Proc. SPIE 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022), 124583L (6 December 2022); https://doi.org/10.1117/12.2660283
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Particles

Breast cancer

Cancer

Tissues

Blood circulation

Lung cancer

Back to Top